One contribution of 13 to a theme issue 'Bioengineering for women's health, volume 1: female health and pathology'. Pelvic floor disorders (PFDs) will affect most women during their lifetime. Sequelae such as pelvic organ prolapse, stress urinary incontinence, chronic pain and dyspareunia significantly impact overall quality of life. Interventions to manage or eliminate symptoms from PFDs aim to restore support of the pelvic floor. Pessaries have been used to mechanically counteract PFDs for thousands of years, but do not offer a cure. By contrast, surgically implanted grafts or mesh offer patients a more permanent resolution but have been in wide use within the pelvis for less than 30 years. In this perspective review, we provide an overview of the main theories underpinning PFD pathogenesis and the animal models used to investigate it. We highlight the clinical outcomes of mesh and grafts before exploring studies performed to elucidate tissue level effects and bioengineering considerations. Considering recent turmoil surrounding transvaginal mesh, the role of pessaries, an impermanent method, is examined as a means to address patients with PFDs.
Introduction
The first mention of a device to assist with symptoms of female pelvic disorders was described by Hippocrates in 400 BC. Women experiencing pelvic organ prolapse (POP) could be inverted on a ladder-like frame and vigorously shaken to move their organs back into place [1] . Since these rudimentary beginnings, devices for pelvic floor disorders (PFDs) have significantly advanced. Women now have a variety of options to correct or manage urinary incontinence and POP resulting from PFDs.
This progress has not been without noteworthy stumbles, both past and present. The need for multidisciplinary teams to create and refine pelvic devices using principles from medicine, tissue regeneration, mechanical engineering and materials science has never been more evident. In this review, we cover successes and failures in modern, implanted devices to treat PFDs with a focus on grafts, meshes and pessaries.
Pelvically implanted grafts and meshes
By the time a woman is 80 years old, she has a 20% chance of undergoing surgery for a PFD. The two most common ailments categorized as PFDs are stress urinary incontinence (SUI) and POP [2] . In SUI, women experience leakage of urine during times of increased abdominal pressure such as jumping, coughing or sneezing. The prevalence of SUI in women is 12-46% throughout their lifetime [3] . POP occurs when the pelvic organs (bladder, rectum and uterus) move from their anatomic position and herniate into the vaginal canal, affecting 50% of parous women [4] .
Understanding the complexities of PFDs was propelled forward through the collaboration of obstetrics and gynaecology and pelvic medicine specialist De Lancey and mechanical engineer Ashton-Miller. Their work revealed how the pelvic floor musculature, associated endopelvic fascia and suspensory ligaments provide support to counter increased intraabdominal pressure; for example, providing a platform to compress the urethra during a cough to maintain continence [5] . Investigations into vaginal birth using three-dimensional geometric modelling demonstrated how the fetal head moving through the genital hiatus stretches the adjacent muscles and nerves to a remarkable degree. The pubococcygeus experiences the greatest stretch ratio of 3.26 (tissue length under stretch/original tissue length) with sections of the muscle likely experiencing significantly greater strain than this average [6] . They propose that damage to pelvic floor muscles through mechanisms such as vaginal birth leads to incomplete closure of the genital hiatus, resulting in caudal displacement of pelvic organs and eventual permanent deformation of the supporting fascia and suspensory ligaments that leads to SUI and POP.
Petros's integral theory/system [7] [8] [9] [10] proposes that the shared origin of PFDs does not originate at the musculature, but instead with the loss of connective tissue integrity due to the same repetitive intraabdominal mechanical stresses highlighted by De Lancey and Ashton-Miller: elevated body mass index, hysterectomy, vaginal birth, increased parity, etc. [7, 8] . The result is an increase in vaginal and ligament laxity [9] . Without strong, supportive connective tissue for pelvic floor muscles to contract against, the muscles are weakened and provide insufficient force to counter increased intraabdominal pressure [10] . The main evidence to support this theory are successful surgical interventions that aim to recreate the supporting role of the connective tissue without intervening on the muscle [9, 11] .
In the twentieth century, surgical treatment of PFDs rapidly evolved. Numerous approaches used sutures to anchor pelvic tissue in place or harvested native muscle or fascia to support weak tissue and alleviate symptoms [1, [12] [13] [14] . However, many repairs using conventional native tissue were short-lived with a 29.2% reoperation rate [15] . Explanations for the high failure rate of autologous tissue include that some women may not have enough suitable native tissue for a proper repair. Additionally, it is hypothesized that vulnerability to PFDs may be explained by dysfunctional extracellular matrix metabolism that weakens pelvic tissues [7] . If a systemic connective tissue dysfunction leads to PFDs, repairs completed with autologous tissue will have high rates of failure. Grafts and synthetic meshes had been used to surgically repair abdominal hernias and gynaecologists began using these materials for supportive repairs to increase durability, decrease operating time and avoid harvest site morbidity.
Synthetic implants are now commonly used in PFD procedures and are among the most controversial materials in medicine. In women with SUI, compressing the urethra with a small midurethral sling of mesh to prevent urinary leakage with increased abdominal pressure is the gold standard of treatment. Over 3 million slings have been implanted since the mid-1990s [16] . Additionally, over the last 20 years, transvaginal mesh or grafts have been placed for POP repairs.
Tissues used for investigation
A significant gap in providing appropriate treatment for PFDs lies in understanding the biomechanical properties of normal pelvic tissue. Theoretically, mesh or grafts would approximate the characteristics of human tissue, but few studies have been done on the biomechanics of healthy, human pelvic tissues from the living [17, 18] , or even cadavers [19] [20] [21] [22] [23] , as they are understandably difficult to acquire. Instead, most work has examined the biomechanical properties of pathological samples removed during surgery [19, [23] [24] [25] [26] , including explants of grafts or mesh. Biomechanical measures from a study examining healthy vaginal tissue removed near the anterior vaginal fornix reported elastic modulus, Poisson's ratio, maximum elongation and maximum fracture. In pre-menopausal tissue it was: 6.65, 0.46, 1.68, 0.79, respectively, and in post-menopausal controls: 10.26, 0.42, 1.37, 0.42, respectively [17] .
Animal models have been a practical way to fill the void left by the lack of studies using healthy human tissue. Small animal models such as mice, rats and rabbits have the advantage of being a low-cost, high-volume means to assess in vivo implant properties. Studies examining the baseline biomechanics of small animal model vaginas are available [27] [28] [29] . Genetically modified mice also provide unique opportunities to examine PFD aetiologies, including enzymatic deficiencies [30, 31] . When comparing small animal studies using abdominally versus vaginally implanted devices, small animals lack sufficient space within the pelvis to support material necessary to complete complex biomechanical testing or reach similarly powered conclusions [32, 33] . Additionally, the animals used in these studies are not known to spontaneously exhibit significant injury from parity like those present in women that are a prime cause of PFDs.
Large animal models include non-human primates, sheep, cows and swine. Because of their more upright posture and the similarity of their pelvic anatomy to that of humans, nonhuman primates may seem like the best candidates for PFD research; however, ethical and economic considerations make them largely impractical [34] . Sheep are currently considered the best-suited model for the study of PFDs owing to their predisposition for POP with and without parity as well as a similarity in reproductive anatomy and similar fetovaginal proportions [35] . In an analysis comparing human and sheep vaginal tissue after birth, sheep were found to undergo similar biomechanical changes to humans [36] .
Non-autologous biological material grafts 2.2.1. Clinical findings
Non-autologous biological material grafts such as allografts (cadaveric tissue) and xenografts (animal tissue) became common in SUI treatment in the 1990s and were approved for POP in 2001. Results from suburethral cadaveric grafts used to treat urinary incontinence were mixed with some demonstrating unacceptable failure rates [37] [38] [39] [40] [41] and others reporting patient satisfaction [42] [43] [44] [45] . Outcomes for xenograft porcine dermis slings were poor. For example, a multicentre prospective randomized control trial (RCT) suspended its porcine dermis arm owing to clear inferiority to both autologous and synthetic slings [46] [47] [48] [49] . Additionally, xenograft RCTs for POP compared porcine dermis, porcine small intestine submucosa and bovine pericardium with traditional anterior repairs 1-3 years after surgery and demonstrated biological material superiority in two studies [50, 51] and no anatomic benefit in the rest [52] [53] [54] [55] [56] . In rectocele repair to restore the rectum to its normal position, xenografts had equal or increased anatomic failure rates, but similar symptomatic outcomes [57] [58] [59] . Overall, biological materials are not recommended for SUI and do not improve anatomic or subjective measures in POP repair [60] .
Histology
Ideally, biological materials will act as scaffolds, undergoing organized host fibroblast infiltration, collagen deposition and royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20190014 neovascularization to mature into load-bearing integrated structures [61, 62] . Tissue histology and biomechanical testing help quantify these outcomes. Unfortunately, histological allograft examination has largely been assessed following implantation outside of the pelvis [63] [64] [65] , and, therefore, limited site-specific information is available. Hilger et al. implanted New Zealand white rabbits vaginally and abdominally with segments of human and porcine dermal grafts or porcine collagen-coated polypropylene mesh grafts [66] . After 12 weeks, dermal grafts had moderate inflammatory changes with minimal peripheral collagen ingrowth or neovascularization compared with synthetic grafts [66] . In humans, a study of failed cadaver suburethral slings demonstrated general degradation and cellular disorganization as opposed to linear remodelling [62] . Woodruff et al. found that failed cadaver grafts exhibited no revascularization and had scant host fibroblasts peripherally infiltrating [67] .
Host immune response to xenografts has been widely studied outside of the pelvis for indications besides PFDs [63, 64, [68] [69] [70] [71] [72] . Within the pelvis, tissue findings with porcine dermis from failed patient and animal graft models have been variable. Histological assessments of grafts postimplantation demonstrate everything from intact scaffolds with some fibroblast infiltration to degeneration, total digestion and even encapsulation [32, 66, 67, 73, 74] . Although some inflammation is beneficial to fibroblast-driven integration, xenografts that experience a heightened immune response and encapsulation are frequently acellular, avascular and unincorporated into tissue. These encapsulated grafts provide little support to the patient [32, 67, 75, 76] .
At the bladder neck of mice or rats, porcine small intestine submucosa demonstrated an early inflammatory reaction that after 60 days to 12 weeks resulted in increased angiogenesis, collagen III production and host cell infiltration [74, 77] . This evidence of improved biocompatibility is supported by patient experiences with small intestine submucosa slings. Vaginal biopsies taken 1 year after sling placement have found only residual implant remaining and no chronic inflammatory response [78] . However, during POP surgeries, following small intestinal submucosa graft complications, implants have been fully replaced by collagen [78, 79] .
Biomechanical testing
Biomechanical testing offers quantifiable data regarding the mechanical properties of grafts that can connect tissue-level experiences to observed clinical outcomes. However, the majority of studies have examined abdominally placed grafts [63, [68] [69] [70] [71] [72] 80, 81] . Only a few studies have looked at structural properties of grafts implanted in the pelvis and are summarized below and in table 1. Prior to implantation, tensiometer measurements of four PFD biological materials were tested. Freeze-dried cadaver fascia lata (deep fascia of the thigh) demonstrated decreased stiffness and tensile strength compared with autologous rectus fascia, solvent-dehydrated cadaveric fascia lata and cadaveric dermal graft. Additionally, freeze-dried fascia lata had a 25% lower maximal load prior to failure as well as the highest intra-tissue variability. Dermal graft had the least intra-tissue variability of the four biomaterials investigated [82] .
Several studies have examined grafts after vaginal implantation. One examined cadaveric fascia lata both before and after 12 weeks in a rabbit vagina. When explanted, tensile strength had decreased 90% [83] . It was postulated that standard pre-implantation processing of freeze-dried tissue may contribute to its poor tensile properties [82] . Another study in rabbits examined three grafts and one porcine collagen-coated mesh (rabbit autologous fascia, cadaveric dermal allograft, non-cross-linked porcine dermis, porcine collagen-coated polypropylene materials) 12 weeks after vaginal or abdominal implantation. When pooled by material, a significant decrease in ultimate tensile strength (87%-allograft; 84%-xenograft) was found compared with autologous fascia (29%). The elastic modulus decreased for both allografts (73%) and xenografts (82%), but increased for autologous fascia (35%). Vaginal location resulted in a large decrease in ultimate strength. It is interesting to note that this testing was completed in only half of vaginal cadaveric and porcine dermal grafts owing to excessive degradation, which was not experienced with abdominal implantation [66] . A similar study looked at the differences in vaginal versus abdominal implantation outcomes for a cross-linked bovine pericardium acellular collagen matrix processed with an anti-calcification procedure. Grafts were implanted for 180 days in the sheep rectovaginal septum, anterior vagina and anterior abdominal wall, along with control animals with lightweight monofilament polypropylene mesh implants. Vaginally explanted grafts were 63% less stiff (N mm
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) than those within the abdomen. Anterior grafts were examined for degradation: 70% experienced some form of degradation, compared with 30% of abdominal grafts. Although the study was insufficiently powered, biomechanical testing of posterior grafts from animals with degradation demonstrated reduced compliance compared with grafts from animals without degradation (0.33 versus 0.15 N mm 21 ). Additionally, smooth muscle contractility from posterior grafts with anteriorly degraded grafts demonstrated 60% less contraction (mN mm
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) to 80 mM potassium solution compared with posteriorly implanted lightweight monofilament polypropylene mesh [84] .
Although it was initially postulated that the histological similarity of biological materials to native tissues would create a more durable repair, implantation site biocompatibility must be considered when developing new grafts. Comparisons with previous studies using abdominal implantation are insufficient to support use in PFDs. Importantly, biological materials may be vulnerable to the same loss of integrity as native tissues if inflammation, poor circulation and inherent enzymatic dysfunction or other causes leading to a poor tissue environment are foundational to the development of PFDs [85] . The unimpressive record of biological materials in the clinical treatment of PFDs along with the immune and mechanical inconsistencies noted above indicate that additional research is required before these materials are ready for PFD repair.
Synthetics (mesh) 2.3.1. Clinical findings
Synthetic (mesh) midurethral slings are the most studied surgical treatment and the current 'gold standard' for SUI [3, 86] . Although non-synthetics have reported similar success [47, [87] [88] [89] [90] [91] , mesh has lower complication rates including decreased urethrolysis, urinary retention and reoperation [89] [90] [91] [92] [93] [94] . In POP repair, polypropylene has demonstrated greater anatomical success during sacral colpopexy than autologous or biological materials [95] [96] [97] . In a number of RCTs, royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20190014 anterior colporrhaphy with polypropylene mesh has been anatomically superior to traditional repair up to 3 years after surgery [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] . However, in the largest RCT to date, mesh did not confer any benefit to patients [56] . Studies comparing polypropylene mesh with xenografts in the anterior vaginal compartment have been mixed [100, 109] . Overall, mesh has gained support for SUI and anterior repairs, but not in other compartments [60] . Regardless of anatomic efficacy, serious concerns regarding complications from transvaginal mesh used in POP repair have emerged. Erosion has been of particular interest with one systematic review finding an erosion rate of 10.3% based on 110 heterogeneous POP repair studies using grafts and/or meshes [110] . In the largest RCT that included 35 different centres, synthetic mesh complications were demonstrated in 12% of patients undergoing primary anterior or posterior repair compared with native tissue [56] . Pain was the most common adverse event reported in POP complication registries. One study specifically investigating pain reported 15.6% of patients had new pelvic pain following mesh surgery for PFD [111] . Sequelae such as pain are missed in most studies as they have been powered to examine anatomic outcomes and do not capture complications or patient-reported quality of life issues [60] . A study of Medicare beneficiaries in the USA found that low-volume surgeons performed more than half of the vaginal prolapse repairs using mesh and had significantly higher rates of reoperation than intermediate-or high-volume surgeons [112] . Thus complications arising from graft or mesh implantation may be due not only to the biomaterial used but also to surgical experience.
As a result of adverse events, beginning in 2017 countries began banning transvaginal mesh or suspending its use, some even dubbing it the new thalidomide [113] . Most recently, in April 2019 the Food and Drug Administration (FDA) in the USA banned the sale and distribution of transvaginal mesh for POP repair. Unfortunately, although synthetics used in midurethral slings report low complication rates including a low exposure rate of 2% and 9 year removal rate of 3%, slings too have been caught in the crossfire [3, 114] .
Review of materials
Prior clinical data demonstrating safety and efficacy were not required when the FDA initially approved transvaginal mesh for POP repair. It was deemed 'substantially equivalent' to previously approved meshes for ventral and inguinal hernias. Surgical mesh products are categorized as class II devices and approved via the 510(k) pathway [115] . Mesh should be flexible, but strong, easily handled and cut to size, chemically and physically inert, resistant to infection and sterilizable [116] . These properties influence clinical outcomes including infection susceptibility, repair durability and erosion potential [117] . The classification system used by pelvic mesh was adopted from abdominal mesh that differentiated materials by pore size and filament type [118] . This classification system was chosen based on primary outcomes of infection, seroma formation and erosion as tested in abdominal hernia repair [119] .
Pore size has received a great deal of attention in the hernia literature because of implications for tissue integration and infection [119] . Microporous mesh contains pores less than 10 mm in at least one direction. This small dimension is believed to not only decrease cellular adhesion and integration, but also increase infection owing to passage and [76, 120] . In conflict with this hypothesis is evidence that macrophages have been shown to penetrate these small spaces [117] . In macroporous mesh ( pore . 75 mm) macrophages, expanding fibrous tissue and blood vessels can traverse the implant unimpeded, decreasing infection and inflammation and allowing for fibrous integration into tissue [76,116 -121] . Filament type is another mesh-defining characteristic. It is interconnected with pore size as macroporous mesh is more likely to be made of a monofilament while multifilament mesh frequently has pores less than 10 mm [122] . The decreased surface area of monofilament mesh compared with multifilament is suggested to be primarily responsible for decreased infection as opposed to pore size [117] . Monofilament mesh is also preferred because of decreased susceptibility to erosion compared with multifilament mesh [85] . Additionally, in one RCT, patients reported better quality of life outcomes with monofilament over multifilament [123] .
Although not part of any classification scheme, stiffness, the extent to which the mesh deforms when acted on by a load, is considered a very important mesh property. Stiffness is defined as the slope of the membrane tension (force/ sample width) versus strain [124] . Materials must be mechanically strong for repair, but when overly rigid may cause thinning of underlying muscles or damage to adjacent tissues [125] . If too pliable, a mesh may nicely conform to a patient's anatomy, but may not provide needed support. Uniaxial testing using loads to failure and cycling loading has been the simplest and most common method to compare mesh stiffness and elasticity. Although this testing may represent the uniaxial forces predicted in sacrocolposuspension and sacrocolpopexy, it is unlikely to provide information about the forces other mesh applications will experience in vivo [124] . Everyday actions like coughing, walking or elimination activities cause multiaxial stress. Ex vivo testing using biaxial/ multiaxial methods has gained ground with several groups performing complex, in-depth analysis of materials [126, 127] . In the lower pelvic or vaginal setting, mesh is subjected to the chronic effects of gravity, making its viscoelastic properties of additional concern [34] . With regard to these complex biomechanical characteristics, many synthetics are still being investigated.
Within the numerous combinations of mesh characteristics, macroporous, monofilament polypropylene is the material most commonly used in PFD surgery [3, 128] . Some of the earliest mesh was made of polypropylene because it could be autoclaved [129] . Polypropylene is frequently classified by its density as lightweight versions demonstrate decreased foreign body reaction, graft shrinkage and fibrosis, with improved integration in abdominal hernia repair [130] . Owing to a number of conflicting pelvic-specific studies and the heterogeneity of the materials involved, the superiority of polypropylene is unclear compared with other synthetic options such as polytetrafluoroethylene or polyethylene terephthalate, but it is certainly the most tested.
Histology
In vivo reactions to synthetic mesh have been widely examined in animals' abdomens, but fewer studies have been completed within the pelvis. Across studies, implantation of polypropylene mesh in the rabbit vagina demonstrated mild inflammation and positive signs of mesh incorporation, including infiltrating smooth muscle bundles, blood vessels and connective tissue [32, 131] . In two rodent models and a rabbit model, polypropylene implantation between the vagina and the bladder led to an acute inflammatory response at 7 days that fell at later time points [132] [133] [134] . In rabbits, the inflammatory response was significantly increased in vaginally implanted mesh compared with abdominally implanted mesh, underscoring the differences in biocompatibility between these locations [32] . Within the vagina, erosion rates were closely correlated with an increase in the length of mesh placed, occurring in 42% of animals with long pieces, but only 10% of animals with shorter mesh implants [32] . Similarly, a study examining mesh size in sheep with rectovaginal septum and abdomen mesh placements found that increased mesh size led to greater exposure rates and mesh contraction (25% versus 52% contraction) with exposure only seen in large vaginally placed mesh [33] . Human studies have also connected the risk of erosion to the surface area of the implant [135] .
Animal models have assessed polypropylene coated with an absorbable collagen matrix or film to decrease adhesions and increase biocompatibility and integration without pathological fibrosis [136] . Sheep models of mesh implantation have found no difference in tissue infiltration or inflammatory response between non-coated and coated polypropylene [136] [137] [138] . When explants were examined early (60 days) and late (180 days) post-implantation, early explants had increased neovascularization and mature collagen was noted with collagen-containing mesh, but no difference was seen in leucocyte populations [138] . In one material (Avaulta Plus), there was an increase in foreign body giant cells around the collagen portion, but not the polypropylene part of the mesh, which suggested an active degradation process at these locations [137] . After vaginal and abdominal implantation in rabbits, collagen-coated polypropylene displayed minimal inflammatory response and moderate erosion, but was also found to have encapsulation of mesh fragments with foreign body reaction [66] . In another rabbit study, collagen-coated mesh had increased cell apoptosis, but overall no differences in inflammation, neovascularization or fibrosis [139] . Overall, the hypothesis that a collagen layer improves tissue response has not been supported by animal model evidence.
Histological study of human tissue from patients having undergone revision, removal or planned biopsy following transvaginal mesh or midurethral sling demonstrated a mild persistent inflammatory reaction to polypropylene [67, [140] [141] [142] [143] [144] . This effect has been seen in prospective vaginal punch biopsies showing increased macrophages and mast cell infiltration 2 years after transvaginal mesh placement [140] . Review of pathology reports from explanted vaginal mesh specimens included the diagnostic terminology 'fibrous/fibrosis' in 70.1% of explants, 'foreign body giant cell reaction' in 18.8% and 'inflammation' in 10.4% [143] . When midurethral sling explants were examined, inflammation was significantly higher in patients with only voiding dysfunction as opposed to those with mesh exposure or a mixed presentation [142] . The observation that there are different tissue reactions based on presentation is further supported by the work of Nolfi et al. When examining polypropylene vaginal explants removed after 4.5-93 months, patient-reported pain was associated with profibrotic interleukin-10 and M2 'proremodelling' macrophages, while those presenting with erosion had an increase in proteolytic matrix metalloproteinase-9, indicating degradation [144] .
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Although the above findings from polypropylene may seem alarming, when compared with other mesh or graft options from human studies, polypropylene fairs better. An analysis of sling revisions that included polypropylene, autologous fascia, porcine dermis, cadaveric dermis and cadaveric fascia revealed that polypropylene explants included more fibroblasts, greater tissue infiltration and less degradation or encapsulation [67] . In another study, the polypropylene product Prolene was prospectively compared with Mersilene, a polyethylene terephthalate, in a midurethral sling procedure. Biopsies obtained after 2 years revealed minimal inflammation with polypropylene, whereas polyethylene terephthalate led to significant inflammation and foreign body reaction [141] .
Biomechanical testing
Ex vivo baseline testing provides an understanding of mesh behaviour prior to implantation. A number of ex vivo studies using uniaxial methods have put a long list of heterogeneous mesh products through testing and are summarized in table 2 [125,126,148 -153] . For prolapse repair, Gynemesh has been the prototype against which others are compared [125] . In many of the ex vivo studies, Gynemesh has been measured as the stiffest of the meshes, a property associated with mesh exposure, but also strength of repair [125, 148] . Biaxial testing and anisotropic biomechanical properties of mesh have become more a focus of recent studies as the utility of examining materials in one direction of movement has come into question given the dynamic three-dimensional nature of the pelvis that is exposed to a number of forces [126, 146, 154, 155] . Ultralight polypropylene Restorelle has been found to be isotropic, while widely known Gynemesh PS and UltraPro are anisotropic [126, 146] . The implication is that materials may be more or less suitable for implantations based on their direction of implantation and the forces they will confront in vivo [146] .
Examination of vaginally placed explants from animal models provides a more realistic idea of how the vaginal environment affects mesh. These studies are described below and summarized in table 3. Most studies of this type have also investigated abdominally placed mesh, allowing for comparisons of biocompatibility between the locations. The earliest studies used parous New Zealand white rabbits vaginally and abdominally implanted with a heterogeneous assortment of commercially available meshes and performed uniaxial biomechanical experiments. One study examined Gynemesh polypropylene nine months after implantation and found that vaginal sections had greater decreased stiffness and increased elasticity than abdominal sections [73] . Two other studies also examined polypropylene monofilament modified with an absorbable layer, either a porcine collagen coat (Pelvitex) [66] or synthetic poliglecaprone (Prolift Plus) [145] . After 12 weeks, the polypropylene with an absorbable biological coating was stronger than the other materials tested. Overall, vaginally implanted materials showed a greater decrease in ultimate strength than abdominal sections [66] . The synthetic absorbable layer made no difference in uniaxial biomechanical testing in explants after 120 or 180 days [145] .
Due to several considerations, including size, rabbits fell out of favour as an animal model for vaginal mesh in favour of larger animals such as rhesus macaques and sheep [145] . One study very realistically performed a hysterectomy and sacral colpopexy on parous rhesus macaques using polypropylene monofilaments of different stiffnesses. Mesh vaginal complexes were explanted at three months and biomechanical and contractility testing performed [147] . Vaginal contractility to high potassium solution was most reduced by Gynemesh PS (280% versus sham) and UltraPro placed perpendicularly (268% versus sham). Ballburst testing assessed passive biomechanical properties, finding that poliglecaprone-containging UltraPro, regardless of orientation, was stiffer than sham while Gynemesh PS and SmartMesh were no different. An additional study implanted Gynemesh with poliglecaprone (Gynemesh M) in the rectovaginal septum and abdominal wall of sheep. A difference in material contraction with minimal change was evident in abdominally placed mesh and significant contraction in vaginal mesh (7.9% versus 46.1%). However, no difference was observed in biomechanical properties during biaxial testing [33] . By contrast, a separate study of biaxial and contractility testing on several polypropylene monofilament products in this same model yielded different results. Mesh vaginal complexes were found to have a longer comfort zone and lower stiffness than abdominal explants, both with and without a collagen matrix [137] . Overall, control vaginal tissues were less stiff than those with mesh. Although early contractility was no different between mesh explants and controls, in the long run, mesh implantation led to decreased vaginal contractility [137] .
This work highlights that, while ex vivo testing provides interesting baseline information for mesh characteristics, implantation can significantly alter these properties. Additionally, although abdominal and vaginal implantations occasionally led to similar biomechanical outcomes, there is frequently a difference in the effects of these two environments. Clinically relevant work will be best completed within the vaginal environment of a large animal model.
Future directions for grafts and mesh
The future of implanted grafts and mesh for PFDs is tenuous. Midurethral slings have a track record of positive clinical outcomes with minimal adverse events, whereas clinical failures have been widely and dramatically publicized with transvaginal mesh. The simple approval process for transvaginal mesh created an unrestricted marketplace without demonstrable research or appropriate oversight. As this review highlights, there is no accepted approach to test pelvically implanted grafts or mesh. The numerous experimental protocols and a large number of manufactured products make meaningful comparisons across studies difficult [156] . The way forward, especially for transvaginal mesh, will require a foundational, step-wise approach focusing on refining the products while exploring new technology to improve PFDs.
Promising areas for future exploration involve creating new implants from alternative polymers [157] , using electrospun biomimetic scaffolds [158] or employing tissueengineering strategies to seed existing grafts or mesh with stem cells [76, 159] . To date, animal studies have demonstrated that muscle-and bone-marrow-derived stem cells can incorporate into the existing pelvic floor musculature and improve contractility [160, 161] . These advancements may be the answer to the immune and biomechanical struggles facing current patients with poor tissue microenvironments.
Using technology to less invasively diagnose and assess PFDs is another exciting area of research. Vaginal tactile royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20190014 royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20190014 imaging proposes to diagnose PFDs using a vaginally inserted probe that measures applied pressure to assess tissue elasticity and pelvic floor support [162] . Magnetic resonance imaging data are forming the basis for computational modelling using finite-element analysis to understand the biomechanical properties of pelvic floor muscles and their pathologies [163] [164] [165] .
Pessaries
Before the advent of inverted succussion or pelvic mesh, women have been treating PFDs by placing objects in the vagina to mechanically obstruct organ descent [166] . In 350 AD, half a vinegar-soaked pomegranate was recommended [1] . Modern pessaries are made of hypoallergenic materials and come in a variety of shapes and sizes to hold back prolapse and relieve pressure on pelvic structures. Pessaries are the first line POP treatment for 77% of urogynaecologists [167] and 69-86% of gynaecologists report prescribing pessaries [168, 169] . Although more effective in POP treatment, since the early 2000s pessaries have been used to treat SUI in the absence of symptomatic prolapse [170] . Several patient factors can influence pessary use. Pessary patients are often older with significant comorbidities or have less advanced PFDs [171, 172] . Those who are younger, have had previous pelvic surgery or have symptoms severely affecting sexual or bowel function are more likely to select surgery [171, 173, 174] . Additionally, patient perceptions and cultural factors impact pessary use, as some women are uncomfortable inserting a device vaginally. Although pessaries have been widely used for thousands of years as an inexpensive, non-surgical means to improve women's quality of life, half of patients establishing care with a urogynaecologist have never heard of pessaries, judge them negatively and only one-third would consider their use [175] .
Clinical outcomes
Pessaries aim to relieve PFD symptoms such as pelvic pain, bladder irritation, prolapse awareness and sexual dysfunction. Despite validated patient questionnaires such as the Female Sexual Function Index and Pelvic Floor Distress Inventory, pessary treatment has not been thoroughly assessed by systematic studies. Most studies available conclude that pessary use improves bother from both prolapse protrusion and bladder symptoms [176] [177] [178] [179] [180] [181] [182] [183] [184] . When conservative pessary treatment is compared with surgical treatment, both groups demonstrate significant improvement in PFD symptoms and quality of life [185] [186] [187] [188] [189] [190] ; however, surgery may lead to greater improvement [185, 187, 189, 190] . Although a vaginally inserted device could interfere with sexual health, sexually active women beginning pessary use report an improvement in sexual function domains [178, 182, 185, 186] .
Pessary use is relatively straight forward and around 85% of women with POP are fitted by trained clinicians with a suitable device [191] . According to a prospective observational study, most failures occur within four weeks of fitting [192] . If successful during this initial period, 53 -86% still use a pessary 3 -5 years later [172, 192, 193] . Traits of those who discontinue use include a history of hysterectomy, history of SUI, sexual inactivity and age less than 65 [194] [195] [196] [197] . Early complications that prompt discontinuation include repeated expulsion, discomfort, inability to personally insert or remove the pessary, vaginal discharge/odour and de novo urinary incontinence [178, 179, [198] [199] [200] . The most common long-term complication is painless vaginal ulceration or erosion, an outcome associated with device neglect that occurs in 2-24% of patients [201] . Rarer complications include vesicovaginal or rectovaginal fistula, urinary tract obstruction and pessary impaction [199, [202] [203] [204] [205] . Pessary use has also been implicated as an inciting factor for vaginal and cervical cancers; however, no studies have proven that pessaries cause vaginal cancer [199, 206, 207] .
Histology
Pessary use and maintenance can change the vaginal environment. Bacterial vaginosis was three times more likely with pessary use [208] and frequency of pessary removal was inversely correlated with anaerobe prevalence [209] . In one historic study, Papanicolaou smears from pessary patients not taking oral oestrogen demonstrated acute inflammatory changes and cytological atypia including atypical metaplasia [206] . Device removal and the use of topical oestrogen was successful in reversing these types of early cytological changes [201] . Foreign body reaction and chronic inflammation have been associated with several cervical and vaginal cancers occurring at the sites of pessary insertion, but the absolute number of cases remains too low to properly evaluate [207, 210] .
Vaginal abrasion rates with pessary use are associated with the thickness of the vaginal epithelium. The incidence of abrasion and erosion increases as the vaginal epithelium becomes atrophic [193] . The effect of hormone replacement on ulceration rates is mixed. Some studies show that prior hormone use had no effect and others describe tissue healing and recommend topical oestrogen for atrophic vaginal tissues both prior to pessary fitting and to treat ulcerations [193, 198, 211, 212] . These findings align with the available low-quality evidence that vaginal oestrogen improves symptoms of vaginal atrophy over placebo [213] . Locally administered oestrogenic preparations are associated with longer pessary use. These preparations are low risk, can be applied topically or placed proximal to the supportive pessary, and exchanged when needed [201, 213, 214] .
Review of materials
Pessary development relied on trial and error, finally arriving at the handful of modern devices in use today. Most pessaries are made from silicone as it is hypoallergenic, durable, sterilizable and biologically inert [201] . Latex is still used in some devices, such as inflatable pessaries, but is contraindicated in those with allergies and tends to absorb vaginal odours [215, 216] .
The types of pessaries most commonly used include the ring, Gehrung, Hodge, Gellhorn, cube and doughnut pessaries. While each has a unique design and preferred use [201, 215] , they are divided into two broad categories: support pessaries (ring, Gehrung and Hodge) and space-filling pessaries (Gellhorn, cube and doughnut) (figure 1). Most patients who can be successfully fitted use either the ring or the Gellhorn, with the chance for finding an effective pessary falling dramatically if other styles must be tried [201] . The most used model is the ring pessary, which can be folded in half for easy patient insertion [167, 169] . It can be kept in place for long periods and may even stay in place during sexual activity. It is also reported to have the fewest complications [217] . The Gellhorn is the most commonly used royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20190014 space-filling pessary and features a concave surface that presses against the vaginal cuff/cervix and an opposing stem positioned towards the introitus. It has been found to be equally efficacious to the ring in several studies, but is mostly used for significant prolapse, especially rectoceles and enteroceles [178, 180, 216, 218] . Although it is not considered to be patient friendly owing to difficulties in insertion and removal, patients tend to use the Gellhorn for a significantly longer time than other pessaries [214] . The cube pessary is of particular interest as it is the only solid pessary to completely occlude the vagina. The cube's concave sides suction to the vaginal mucosa to prevent expulsion. It is frequently a last resort for patients who have failed other pessary options. Although effective, one disadvantage is the trapping of vaginal secretions proximal to the device, predisposing the user to ulcerations and erosion [193, 217] .
Future directions
Evidence supports that many women would benefit from conservative treatment with a pessary before seeking surgery for PFDs. However, to date, there are limited RCT data to guide both patient selection and continued advancement in pessary design [4, 180] . Concerns regarding the safety and efficacy of surgical options to treat PFDs make this a great opportunity to expand evidence-driven research in this field. Another area in which pessaries have recently been used is in the prevention of pre-term births. Studies are currently examining the efficacy of cervical pessaries with and without vaginal progesterone in women with placenta praevia, short cervix or twin gestation [219, 220] .
Overall summary
Pelvically implanted devices for SUI and POP have proven successes and failures over the years. Overall, they improve the quality of life of women with disease and prevent unwanted pregnancies. To continue to develop safe, efficacious implantable devices biomedical engineers need to partner with bench scientists and clinicians to best model patient conditions. This multidisciplinary approach will ensure success and safety of the device and avoid many of the trials and tribulations described in this review. royalsocietypublishing.org/journal/rsfs Interface Focus 9: 20190014
